VELOXIS PHARMACEUTICALS, INC.
Data ndekọ gọọmentị
0ndị na-eso
2016tọrọ ntọala
Maka VELOXIS PHARMACEUTICALS, INC.
Veloxis Pharmaceuticals A/S, formerly LifeCycle Pharma A/S, develops improved versions of difficult-to-formulate drugs with its proprietary drug formulation technology, called MeltDose®. Veloxis is focused on building a clinical and market-stage pharmaceutical business around its late-stage transplant immunosuppression product candidate LCP-Tacro. The company was founded in 2002 as a spin-off from H. Lundbeck A/S. Veloxis is headquartered in Hørsholm, Denmark, with an office in Cary, North Carolina.
Source: Wikipedia
Isi ụlọ ọrụ2000 Regency Parkway, 27518, Cary, US
Tọrọ ntọala2016
ỌnọdụNa-arụ ọrụ
Patent5 patent
Stabilized tacrolimus compositionUS12403095B2 · 2025
STABILIZED TACROLIMUS COMPOSITIONUS2023101012A1 · 2023
Banye iji hụ patentị 5 niile
Chọgharịa pọtụfoliyo patentị zuru ezu, tinyere nọmba mbipụta, ụbọchị na ezinụlọ.
Banye Mepụta akaụntụ site n'ozi-e gịỌ bụ n'efu
Site n'ịga n'ihu, ị na-ekweta Nkwekọrịta onye ojiji, Amụma nzuzo na Amụma kuki nke Heelky.
Nyocha
Enweghị nyocha ugbu a. Ị rụrụ ọrụ na VELOXIS PHARMACEUTICALS, INC.? Bụrụ onye mbụ kekọrịta ahụmahụ gị.
Ozi iwu
| Aha iwu | VELOXIS PHARMACEUTICALS, INC. |
|---|---|
| LEI | 549300YD7MO7TUE8GX79Lee na GLEIF ↗ |
| Adreesị edebanyere aha | 2000 Regency Parkway, 27518, Cary, US |
| Ọnọdụ | Na-arụ ọrụ |
Isi mmalite: GLEIF · emelitere 16 Ọktoba 2026
Kọntaktị & njikọ
Ebe
2000 Regency Parkway, 27518, Cary, US
Nke a ọ bụ ụlọ ọrụ gị?
Kwuo ibe a n'efu iji tinye logo gị, ngwaahịa, foto na ọrụ, na iza nyocha.
Kwuo ibe aSonye na Heelky iji jikọọ, were ndị ọrụ ma too
Mepụta akaụntụ efu iji zipụ ndị mmadụ ozi, tinye arịrịọ ọrụ ma bipụta mishọn.
Sonye ugbu a — ọ bụ n'efu